SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-023475
Filing Date
2020-02-20
Accepted
2020-02-20 17:24:43
Documents
3
Period of Report
2020-02-13
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm209525d1_8k.htm 8-K 25938
2 EXHIBIT 2.1 tm209525d1_ex2-1.htm EX-2.1 432364
3 EXHIBIT 99.1 tm209525d1_ex99-1.htm EX-99.1 116636
  Complete submission text file 0001104659-20-023475.txt   576278
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Filer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13111 | Film No.: 20636441
SIC: 2834 Pharmaceutical Preparations